Blood Banking Devices Market to Triple by 2034, Fueled by Global Expansion of Blood Banks
Event summary
- The global blood banking devices market was valued at USD 3.26 billion in 2024 and is projected to reach USD 9.08 billion by 2034, growing at a CAGR of 10.80%.
- The market is driven by the increasing number of blood banks and healthcare facilities worldwide, particularly in North America, which dominates due to robust healthcare infrastructure and advanced technologies.
- Blood processing equipment is the largest segment, essential for generating critical blood components like plasma and platelets.
- High costs of devices and operational expenses pose significant barriers to adoption, particularly in resource-constrained settings.
- Recent developments include Terumo's launch of the Reveos™ Automated Blood Processing System and BD's introduction of the BD Vacutainer® UltraTouch™ Push Button Blood Collection Set.
The big picture
The blood banking devices market is experiencing significant growth due to the rising number of blood banks and the increasing need for blood transfusions globally. Technological advancements and automation are key drivers, while high costs and regulatory challenges pose barriers. North America leads the market, supported by strong healthcare infrastructure and advanced technologies, but emerging markets are rapidly gaining traction.
What we're watching
- Technological Innovation
- How advancements in automation, AI, and data analytics will enhance efficiency and safety in blood banking devices.
- Regulatory Compliance
- Whether evolving regulatory requirements will impact the adoption and development of new blood banking technologies.
- Market Expansion
- The pace at which emerging markets, particularly in Asia Pacific and Latin America, will drive demand for blood banking devices.
Related topics